158 related articles for article (PubMed ID: 18167003)
1. IORT and external beam irradiation (EBI) in clinical stage I-II NSCLC patients with severely compromised pulmonary function: an 52-patient single-institutional experience.
Jakse G; Kapp KS; Geyer E; Oechs A; Maier A; Gabor S; Jüttner FM
Strahlenther Onkol; 2007 Dec; 183 Spec No 2():24-5. PubMed ID: 18167003
[No Abstract] [Full Text] [Related]
2. [The combined treatment of lung cancer with one-time large-fraction preoperative irradiation].
Kharchenko VP; Galil-Ogly GA; Chkhikvadze VD; Pan'shin GA; Goncharova IM; Sotnikov VM
Vopr Onkol; 1990; 36(7):863-6. PubMed ID: 2169141
[TBL] [Abstract][Full Text] [Related]
3. [Surgery in non-small cell lung cancer of the superior sulcus: results of a combined preoperative and postoperative irradiation regime].
Pfannschmidt J; Muley T; Hoffmann H; Dienemann H
Zentralbl Chir; 2004 Aug; 129(4):270-5. PubMed ID: 15354247
[TBL] [Abstract][Full Text] [Related]
4. Evaluating intraoperative radiation therapy (IORT) and external beam radiation therapy (EBRT) in non-small cell lung cancer (NSCLC). Five years experience.
Smolle-Juettner FM; Geyer E; Kapp KS; Ratzenhofer B; Stuecklschweiger G; Kaufmann NB; Smolle J; Pongratz GM; Hackl A; Friehs G
Eur J Cardiothorac Surg; 1994; 8(10):511-6. PubMed ID: 7826646
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of gross tumor volume for definitive radiation therapy in patients with locoregionally recurrent non-small-cell lung cancer after surgical resection.
Lee NK; Moon SH; Kim TH; Han JY; Yun T; Kim HT; Lee HS; Kim MS; Lee JM; Cho KH; Lee JS
Clin Lung Cancer; 2013 Jul; 14(4):399-406. PubMed ID: 23276823
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 2--a predictor of outcome for patients irradiated for stage II-III non-small-cell lung cancer.
Rades D; Setter C; Dahl O; Schild SE; Noack F
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):442-7. PubMed ID: 20950963
[TBL] [Abstract][Full Text] [Related]
7. [The surgical therapy of stage-III pulmonary cancer. Comments on 71 cases].
Briccoli A; Beghi M; Farinetti A; Guernelli N
Minerva Med; 1989 Jul; 80(7):677-8. PubMed ID: 2550849
[No Abstract] [Full Text] [Related]
8. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
Qiu C; Dong W; Su B; Liu Q; Du J
J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
[TBL] [Abstract][Full Text] [Related]
9. Results of proton beam therapy without concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer.
Oshiro Y; Mizumoto M; Okumura T; Hashimoto T; Fukumitsu N; Ohkawa A; Kanemoto A; Hashii H; Ohno T; Sakae T; Tsuboi K; Sakurai H
J Thorac Oncol; 2012 Feb; 7(2):370-5. PubMed ID: 22157368
[TBL] [Abstract][Full Text] [Related]
10. eComment: Therapeutic options for bronchial stump infiltration following lung cancer surgery.
Barbetakis N; Asteriou C; Kleontas A; Tsilikas C
Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):186. PubMed ID: 19628536
[No Abstract] [Full Text] [Related]
11. Potentially curative radiotherapy for non-small-cell lung cancer in Norway: a population-based study of survival.
Strand TE; Brunsvig PF; Johannessen DC; Sundstrøm S; Wang M; Hornslien K; Bremnes RM; Stensvold A; Garpestad O; Norstein J
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):133-41. PubMed ID: 20452137
[TBL] [Abstract][Full Text] [Related]
12. Preoperative concurrent radiation therapy and cisplatinum continuous infusion in IIIa (N2) non small cell lung cancer. A pilot study.
Maggi G; Casadio C; Cianci R; Oliaro A; Molinatti M; Bretti S; Clerico M; Boidi-Trotti A; Rovea P
J Cardiovasc Surg (Torino); 1994 Aug; 35(4):341-6. PubMed ID: 7929550
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications.
Okami J; Higashiyama M; Asamura H; Goya T; Koshiishi Y; Sohara Y; Eguchi K; Mori M; Nakanishi Y; Tsuchiya R; Miyaoka E;
J Thorac Oncol; 2009 Oct; 4(10):1247-53. PubMed ID: 19609223
[TBL] [Abstract][Full Text] [Related]
14. Survival and treatment of non-small cell lung cancer stage I-II treated surgically or with stereotactic body radiotherapy: patient and tumor-specific factors affect the prognosis.
Mokhles S; Nuyttens JJ; Maat AP; Birim Ö; Aerts JG; Bogers AJ; Takkenberg JJ
Ann Surg Oncol; 2015 Jan; 22(1):316-23. PubMed ID: 24962941
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of the primary tumor location based on the hilar structures in non-small cell lung cancer with mediastinal lymph node metastasis.
Ito M; Yamashita Y; Miyata Y; Ohara M; Tsutani Y; Ikeda T; Misumi K; Harada H; Omori K
Lung Cancer; 2012 Apr; 76(1):93-7. PubMed ID: 22285532
[TBL] [Abstract][Full Text] [Related]
16. Lymph node ratio may predict the benefit of postoperative radiotherapy in non-small-cell lung cancer.
Urban D; Bar J; Solomon B; Ball D
J Thorac Oncol; 2013 Jul; 8(7):940-6. PubMed ID: 23695418
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment of primary lung cancer with synchronous brain metastases.
Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
[TBL] [Abstract][Full Text] [Related]
18. [Extensive and combined resections in poorly differentiated lung cancer].
Shalaev SA; Grishakov SV; Shnitko SN; Chalisov IA; Starikov VA
Vestn Khir Im I I Grek; 1992 Apr; 148(4):43-9. PubMed ID: 1338884
[TBL] [Abstract][Full Text] [Related]
19. Swedish lung cancer radiation study group: predictive value of histology for radiotherapy response in patients with non-small cell lung cancer.
Holgersson G; Bergström S; Bergqvist M; Nyman J; Hoye E; Helsing M; Friesland S; Holgersson M; Birath E; Ekman S; Blystad T; Ewers SB; Mörth C; Löden B; Henriksson R
Eur J Cancer; 2011 Nov; 47(16):2415-21. PubMed ID: 21726999
[TBL] [Abstract][Full Text] [Related]
20. Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival.
Werner-Wasik M; Scott C; Cox JD; Sause WT; Byhardt RW; Asbell S; Russell A; Komaki R; Lee JS
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1475-82. PubMed ID: 11121651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
